EyePoint, Inc. Marketable Securities (Current)
EyePoint, Inc. (EYPT) had Marketable Securities (Current) of $70.01 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-05
- 2026-06-30: Marketable Securities, Current $70.01M.
- 2026-03-31: Marketable Securities, Current $144.83M.
- 2025-12-31: Marketable Securities, Current $204.26M.
- 2025-09-30: Marketable Securities, Current $129.44M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $70.01M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $144.83M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $204.26M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $129.44M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $184.59M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $233.04M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $271.21M 10-K · filed 2026-03-05 |
| 2024-09-30 | $173.96M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $189.48M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $28.34M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $49.79M 10-K · filed 2025-03-06 |
| 2023-09-30 | $2.98M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $2.94M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $16.72M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $48.93M 10-K · filed 2024-03-08 |
| 2022-09-30 | $81.90M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $89.03M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $89.24M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $32.97M 10-K · filed 2023-03-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-14 |
| 2017-03-31 | $2.50M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $5.85M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $8.24M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $13.68M 10-Q · filed 2017-05-08 |
| 2016-03-31 | $8.41M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $9.88M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $9.92M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $9.41M 10-K · filed 2016-09-13 |
| 2015-03-31 | $8.65M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $5.93M 10-Q · filed 2015-02-06 |
| 2014-09-30 | $2.92M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $2.94M 10-K · filed 2015-09-10 |
| 2014-03-31 | $2.71M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $502.00K 10-Q · filed 2014-02-12 |
| 2013-09-30 | $1.91M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $3.37M 10-K · filed 2014-09-11 |
| 2013-03-31 | $5.70M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $6.31M 10-Q · filed 2013-02-08 |
| 2012-09-30 | $9.26M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $9.95M 10-K · filed 2013-09-27 |
| 2012-03-31 | $10.09M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $10.27M 10-Q · filed 2012-02-09 |
| 2011-09-30 | $11.46M 10-Q/A · filed 2011-11-09 |
| 2011-06-30 | $11.22M 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |